Prognostic role of BiP/GRP78 expression as ER stress in patients with gastric adenocarcinoma

PURPOSE: The glucose-regulated protein 78 (GRP78), also referred to as immunoglobulin heavy chain binding protein (BiP) (BiP/GRP78), is a major molecular chaperone in the endoplasmic reticulum (ER) and is extensively expressed in human neoplasms. Although the enhanced expression of BiP/GRP78 has bee...

Full description

Saved in:
Bibliographic Details
Published inCancer biomarkers : section A of Disease markers Vol. 20; no. 3; pp. 273 - 281
Main Authors Ogawa, Hiroomi, Kaira, Kyoichi, Takahashi, Kengo, Shimizu, Akira, Altan, Bolag, Yoshinari, Daisuke, Asao, Takayuki, Oyama, Tetsunari
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 07.09.2017
Sage Publications Ltd
Subjects
Online AccessGet full text
ISSN1574-0153
1875-8592
1875-8592
DOI10.3233/CBM-170062

Cover

Abstract PURPOSE: The glucose-regulated protein 78 (GRP78), also referred to as immunoglobulin heavy chain binding protein (BiP) (BiP/GRP78), is a major molecular chaperone in the endoplasmic reticulum (ER) and is extensively expressed in human neoplasms. Although the enhanced expression of BiP/GRP78 has been described to be associated with poor prognosis in gastric cancer (GC), details regarding its prognostic significance remain unclear. The aim of this study was to elucidate the prognostic role of BiP/GRP78 in patients with GC. METHODS: Study subjects included 328 patients who underwent surgical resection. Tumor specimens of primary tumors underwent immunohistochemical staining for BiP/GRP78. RESULTS: BiP/GRP78 was highly expressed in 57% (188/328) of patients. High expression of BiP/GRP78 was significantly associated with older age, male, disease staging, T factor, lymph node metastases, differentiation, lymphatic permeation, and vascular invasion. According to univariate analysis, age, disease staging, T factor, N factor, lymphatic permeation, vascular invasion, and BiP/GRP78 expression were significant prognostic factors for OS. In particular, high BiP/GRP78 expression was proven to be a significant predictor of prognosis in patients with older age, female sex, early disease stage, T1-2 factor, well or moderately differentiated tumors, and negative vascular invasion. CONCLUSION: BiP/GRP78 is significantly associated with tumor aggressiveness and progression. The increased expression of BiP/GRP78 was identified as an independent factor for predicting poor OS in patients with early stage of disease, especially T1-2 factor.
AbstractList The glucose-regulated protein 78 (GRP78), also referred to as immunoglobulin heavy chain binding protein (BiP) (BiP/GRP78), is a major molecular chaperone in the endoplasmic reticulum (ER) and is extensively expressed in human neoplasms. Although the enhanced expression of BiP/GRP78 has been described to be associated with poor prognosis in gastric cancer (GC), details regarding its prognostic significance remain unclear. The aim of this study was to elucidate the prognostic role of BiP/GRP78 in patients with GC.PURPOSEThe glucose-regulated protein 78 (GRP78), also referred to as immunoglobulin heavy chain binding protein (BiP) (BiP/GRP78), is a major molecular chaperone in the endoplasmic reticulum (ER) and is extensively expressed in human neoplasms. Although the enhanced expression of BiP/GRP78 has been described to be associated with poor prognosis in gastric cancer (GC), details regarding its prognostic significance remain unclear. The aim of this study was to elucidate the prognostic role of BiP/GRP78 in patients with GC.Study subjects included 328 patients who underwent surgical resection. Tumor specimens of primary tumors underwent immunohistochemical staining for BiP/GRP78.METHODSStudy subjects included 328 patients who underwent surgical resection. Tumor specimens of primary tumors underwent immunohistochemical staining for BiP/GRP78.BiP/GRP78 was highly expressed in 57% (188/328) of patients. High expression of BiP/GRP78 was significantly associated with older age, male, disease staging, T factor, lymph node metastases, differentiation, lymphatic permeation, and vascular invasion. According to univariate analysis, age, disease staging, T factor, N factor, lymphatic permeation, vascular invasion, and BiP/GRP78 expression were significant prognostic factors for OS. In particular, high BiP/GRP78 expression was proven to be a significant predictor of prognosis in patients with older age, female sex, early disease stage, T1-2 factor, well or moderately differentiated tumors, and negative vascular invasion.RESULTSBiP/GRP78 was highly expressed in 57% (188/328) of patients. High expression of BiP/GRP78 was significantly associated with older age, male, disease staging, T factor, lymph node metastases, differentiation, lymphatic permeation, and vascular invasion. According to univariate analysis, age, disease staging, T factor, N factor, lymphatic permeation, vascular invasion, and BiP/GRP78 expression were significant prognostic factors for OS. In particular, high BiP/GRP78 expression was proven to be a significant predictor of prognosis in patients with older age, female sex, early disease stage, T1-2 factor, well or moderately differentiated tumors, and negative vascular invasion.BiP/GRP78 is significantly associated with tumor aggressiveness and progression. The increased expression of BiP/GRP78 was identified as an independent factor for predicting poor OS in patients with early stage of disease, especially T1-2 factor.CONCLUSIONBiP/GRP78 is significantly associated with tumor aggressiveness and progression. The increased expression of BiP/GRP78 was identified as an independent factor for predicting poor OS in patients with early stage of disease, especially T1-2 factor.
The glucose-regulated protein 78 (GRP78), also referred to as immunoglobulin heavy chain binding protein (BiP) (BiP/GRP78), is a major molecular chaperone in the endoplasmic reticulum (ER) and is extensively expressed in human neoplasms. Although the enhanced expression of BiP/GRP78 has been described to be associated with poor prognosis in gastric cancer (GC), details regarding its prognostic significance remain unclear. The aim of this study was to elucidate the prognostic role of BiP/GRP78 in patients with GC. Study subjects included 328 patients who underwent surgical resection. Tumor specimens of primary tumors underwent immunohistochemical staining for BiP/GRP78. BiP/GRP78 was highly expressed in 57% (188/328) of patients. High expression of BiP/GRP78 was significantly associated with older age, male, disease staging, T factor, lymph node metastases, differentiation, lymphatic permeation, and vascular invasion. According to univariate analysis, age, disease staging, T factor, N factor, lymphatic permeation, vascular invasion, and BiP/GRP78 expression were significant prognostic factors for OS. In particular, high BiP/GRP78 expression was proven to be a significant predictor of prognosis in patients with older age, female sex, early disease stage, T1-2 factor, well or moderately differentiated tumors, and negative vascular invasion. BiP/GRP78 is significantly associated with tumor aggressiveness and progression. The increased expression of BiP/GRP78 was identified as an independent factor for predicting poor OS in patients with early stage of disease, especially T1-2 factor.
PURPOSE: The glucose-regulated protein 78 (GRP78), also referred to as immunoglobulin heavy chain binding protein (BiP) (BiP/GRP78), is a major molecular chaperone in the endoplasmic reticulum (ER) and is extensively expressed in human neoplasms. Although the enhanced expression of BiP/GRP78 has been described to be associated with poor prognosis in gastric cancer (GC), details regarding its prognostic significance remain unclear. The aim of this study was to elucidate the prognostic role of BiP/GRP78 in patients with GC. METHODS: Study subjects included 328 patients who underwent surgical resection. Tumor specimens of primary tumors underwent immunohistochemical staining for BiP/GRP78. RESULTS: BiP/GRP78 was highly expressed in 57% (188/328) of patients. High expression of BiP/GRP78 was significantly associated with older age, male, disease staging, T factor, lymph node metastases, differentiation, lymphatic permeation, and vascular invasion. According to univariate analysis, age, disease staging, T factor, N factor, lymphatic permeation, vascular invasion, and BiP/GRP78 expression were significant prognostic factors for OS. In particular, high BiP/GRP78 expression was proven to be a significant predictor of prognosis in patients with older age, female sex, early disease stage, T1-2 factor, well or moderately differentiated tumors, and negative vascular invasion. CONCLUSION: BiP/GRP78 is significantly associated with tumor aggressiveness and progression. The increased expression of BiP/GRP78 was identified as an independent factor for predicting poor OS in patients with early stage of disease, especially T1-2 factor.
PURPOSE: The glucose-regulated protein 78 (GRP78), also referred to as immunoglobulin heavy chain binding protein (BiP) (BiP/GRP78), is a major molecular chaperone in the endoplasmic reticulum (ER) and is extensively expressed in human neoplasms. Although the enhanced expression of BiP/GRP78 has been described to be associated with poor prognosis in gastric cancer (GC), details regarding its prognostic significance remain unclear. The aim of this study was to elucidate the prognostic role of BiP/GRP78 in patients with GC. METHODS: Study subjects included 328 patients who underwent surgical resection. Tumor specimens of primary tumors underwent immunohistochemical staining for BiP/GRP78. RESULTS: BiP/GRP78 was highly expressed in 57% (188/328) of patients. High expression of BiP/GRP78 was significantly associated with older age, male, disease staging, T factor, lymph node metastases, differentiation, lymphatic permeation, and vascular invasion. According to univariate analysis, age, disease staging, T factor, N factor, lymphatic permeation, vascular invasion, and BiP/GRP78 expression were significant prognostic factors for OS. In particular, high BiP/GRP78 expression was proven to be a significant predictor of prognosis in patients with older age, female sex, early disease stage, T1-2 factor, well or moderately differentiated tumors, and negative vascular invasion. CONCLUSION: BiP/GRP78 is significantly associated with tumor aggressiveness and progression. The increased expression of BiP/GRP78 was identified as an independent factor for predicting poor OS in patients with early stage of disease, especially T1-2 factor.
Author Yoshinari, Daisuke
Shimizu, Akira
Asao, Takayuki
Oyama, Tetsunari
Ogawa, Hiroomi
Altan, Bolag
Kaira, Kyoichi
Takahashi, Kengo
Author_xml – sequence: 1
  givenname: Hiroomi
  surname: Ogawa
  fullname: Ogawa, Hiroomi
  organization: , Gunma 371-8511
– sequence: 2
  givenname: Kyoichi
  surname: Kaira
  fullname: Kaira, Kyoichi
  email: kkaira1970@yahoo.co.jp
  organization: , Gunma 371-8511
– sequence: 3
  givenname: Kengo
  surname: Takahashi
  fullname: Takahashi, Kengo
  organization: , Gunma 371-8511
– sequence: 4
  givenname: Akira
  surname: Shimizu
  fullname: Shimizu, Akira
  organization: , Gunma 371-8511
– sequence: 5
  givenname: Bolag
  surname: Altan
  fullname: Altan, Bolag
  organization: , Gunma 371-8511
– sequence: 6
  givenname: Daisuke
  surname: Yoshinari
  fullname: Yoshinari, Daisuke
  organization: , Gunma 371-8511
– sequence: 7
  givenname: Takayuki
  surname: Asao
  fullname: Asao, Takayuki
  organization: , Gunma 371-8511
– sequence: 8
  givenname: Tetsunari
  surname: Oyama
  fullname: Oyama, Tetsunari
  organization: , Gunma 371-8511
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28854502$$D View this record in MEDLINE/PubMed
BookMark eNptkdtKAzEQhoMoVqs3PoAEvFCE1Rx3N5daPIFiKXonLGmSrZFtUpMU9e1NqYpUb-bAfPMzzL8N1p13BoA9jE4oofR0cH5X4AqhkqyBLVxXvKi5IOu55hUrEOa0B7ZjfEGIUUzEJuiRuuaMI7IFnobBT5yPySoYfGegb-G5HZ5ejYZVDc37LJgYrXdQRngxgjEtemgdnMlkjUsRvtn0DCcyT7KE1MZ5JYOyzk_lDthoZRfN7lfug8fLi4fBdXF7f3UzOLstFGVVKsqy1LwSSHBEEddMMkNaloOoqaSs1cIYTfhYYkXGSGhVayFLOVZY06oUmPbB0VJ3Fvzr3MTUTG1UpuukM34eGywoIzXGFGX0YAV98fPg8nWZElRUBLGF4P4XNR9PjW5mwU5l-Gi-_5aB4yWggo8xmPYHwahZmNJkU5qlKRlGK7CyKb_PuxSk7f5fOVyuRDkxv078S34CDAyYLA
CitedBy_id crossref_primary_10_2174_1871520622666220823094350
crossref_primary_10_1016_j_cellsig_2023_110719
crossref_primary_10_1016_j_prp_2023_154301
crossref_primary_10_1166_jbn_2021_3107
crossref_primary_10_1155_2020_9430737
crossref_primary_10_1016_j_canlet_2019_01_034
crossref_primary_10_1021_acs_jafc_1c07927
crossref_primary_10_3892_ijo_2022_5431
crossref_primary_10_3389_fphys_2020_00177
crossref_primary_10_1038_s41420_022_00950_5
crossref_primary_10_15407_ubj91_03_065
crossref_primary_10_1515_oncologie_2023_0394
crossref_primary_10_1080_19490976_2021_2015238
crossref_primary_10_1016_j_bbcan_2022_188781
crossref_primary_10_2174_2212697X08666211006100250
crossref_primary_10_1002_adhm_202300913
Cites_doi 10.1016/j.humpath.2007.11.009
10.1158/0008-5472.CAN-10-0339
10.1016/j.lungcan.2004.12.011
10.4161/cbt.5.7.2970
10.1016/j.yexmp.2014.02.011
10.1023/A:1006102411439
10.1007/s13277-016-5139-2
10.2174/156652406775574523
10.1186/1477-7819-12-121
10.1016/S0929-6646(10)60060-5
10.1016/0092-8674(94)90518-5
10.1016/j.urology.2009.05.007
10.4149/319_151002N513
10.1007/s10120-004-0289-0
10.1016/j.humpath.2007.03.014
10.1002/hed.21287
10.1007/s10585-006-9051-9
10.1016/j.ccr.2004.08.018
10.1007/s12072-014-9582-0
10.1073/pnas.0807691105
ContentType Journal Article
Copyright 2017 – IOS Press and the authors. All rights reserved
Copyright IOS Press BV 2017
Copyright_xml – notice: 2017 – IOS Press and the authors. All rights reserved
– notice: Copyright IOS Press BV 2017
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TM
7TO
7U7
C1K
H94
K9.
7X8
DOI 10.3233/CBM-170062
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Toxicology Abstracts
Environmental Sciences and Pollution Management
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Oncogenes and Growth Factors Abstracts
Toxicology Abstracts
Nucleic Acids Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1875-8592
EndPage 281
ExternalDocumentID 28854502
10_3233_CBM_170062
10.3233_CBM-170062
Genre Journal Article
GroupedDBID ---
0R~
123
29B
4.4
53G
6J9
AAFNC
ABDBF
ABJNI
ABUBZ
ACGFS
ACHEB
ACPQW
ACPRK
ACUHS
ADZMO
AEGXH
AENEX
AFRAH
AFRHK
AFRWT
AGIAB
ALMA_UNASSIGNED_HOLDINGS
CAG
COF
DU5
EBD
EBS
EJD
EMOBN
ESX
F5P
H13
HZ~
IL9
IOS
J8X
MET
MIO
MV1
NGNOM
O9-
SAUOL
SCNPE
SFC
SV3
TUS
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TM
7TO
7U7
C1K
H94
K9.
7X8
ID FETCH-LOGICAL-c347t-666d5790950305d4a4e2f44e2983a34fd9eed25ba1c2b09dc8d9a6abc1d376913
IEDL.DBID AFRWT
ISSN 1574-0153
1875-8592
IngestDate Fri Jul 11 00:40:02 EDT 2025
Mon Jun 30 08:14:12 EDT 2025
Thu Jan 02 23:11:43 EST 2025
Tue Jul 01 05:27:23 EDT 2025
Thu Apr 24 23:06:15 EDT 2025
Sun Jul 06 05:40:39 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords ER stress
BiP
GRP78
Gastric Cancer
immunohistochemistry
prognosis
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c347t-666d5790950305d4a4e2f44e2983a34fd9eed25ba1c2b09dc8d9a6abc1d376913
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 28854502
PQID 1993972041
PQPubID 2046387
PageCount 9
ParticipantIDs proquest_miscellaneous_1934281130
proquest_journals_1993972041
pubmed_primary_28854502
crossref_primary_10_3233_CBM_170062
crossref_citationtrail_10_3233_CBM_170062
sage_journals_10_3233_CBM_170062
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-Sep-07
PublicationDateYYYYMMDD 2017-09-07
PublicationDate_xml – month: 09
  year: 2017
  text: 2017-Sep-07
  day: 07
PublicationDecade 2010
PublicationPlace London, England
PublicationPlace_xml – name: London, England
– name: Netherlands
– name: London
PublicationTitle Cancer biomarkers : section A of Disease markers
PublicationTitleAlternate Cancer Biomark
PublicationYear 2017
Publisher SAGE Publications
Sage Publications Ltd
Publisher_xml – name: SAGE Publications
– name: Sage Publications Ltd
References Desai 2004; 7
Takahashi 2016; 37
Zheng 2008; 39
Xia 2014; 12
Fu, Lee 2006; 5
Kaira 2016; 63
Hendershot 2004; 71
Gazit, Lu, Lee 1999; 54
Uramoto 2005; 49
Yang 2014; 96
Daneshmand 2007; 38
Arap 2004; 6
Fisher 1994; 78
Passarella 2010; 70
Lin 2010; 32
Huang 2010; 109
Zhang 2006; 23
Fu 2010; 75
Li, Lee 2006; 6
Vandewynckel 2015; 9
Uramoto (10.3233/CBM-170062_ref9) 2005; 49
Li (10.3233/CBM-170062_ref3) 2006; 6
Daneshmand (10.3233/CBM-170062_ref11) 2007; 38
Xia (10.3233/CBM-170062_ref5) 2014; 12
Huang (10.3233/CBM-170062_ref7) 2010; 109
Arap (10.3233/CBM-170062_ref21) 2004; 6
Gazit (10.3233/CBM-170062_ref4) 1999; 54
Vandewynckel (10.3233/CBM-170062_ref8) 2015; 9
Passarella (10.3233/CBM-170062_ref20) 2010; 70
Lin (10.3233/CBM-170062_ref6) 2010; 32
Yang (10.3233/CBM-170062_ref14) 2014; 96
Takahashi (10.3233/CBM-170062_ref15) 2016; 37
Fu (10.3233/CBM-170062_ref18) 2006; 5
Zhang (10.3233/CBM-170062_ref10) 2006; 23
Fisher (10.3233/CBM-170062_ref17) 1994; 78
Fu (10.3233/CBM-170062_ref12) 2010; 75
Desai (10.3233/CBM-170062_ref1) 2004; 7
10.3233/CBM-170062_ref19
Kaira (10.3233/CBM-170062_ref16) 2016; 63
Hendershot (10.3233/CBM-170062_ref2) 2004; 71
Zheng (10.3233/CBM-170062_ref13) 2008; 39
References_xml – volume: 78
  start-page: 539
  year: 1994
  end-page: 542
  article-title: Apoptosis in cancer therapy: crossing the threshold
  publication-title: Cell
– volume: 109
  start-page: 326
  year: 2010
  end-page: 337
  article-title: Decreased GRP78 protein expression is a potential prognostic marker of oral squamous cell carcinoma in Taiwan
  publication-title: J Formos Med Assoc
– volume: 49
  start-page: 55
  year: 2005
  end-page: 62
  article-title: Expression of endoplasmic reticulum molecular chaperone Grp78 in human lung cancer and its clinical significance
  publication-title: Lung Cancer
– volume: 6
  start-page: 45
  year: 2006
  end-page: 54
  article-title: Stress induction of GRP78/BiP and its role in cancer
  publication-title: Curr Mol Med
– volume: 23
  start-page: 401
  year: 2006
  end-page: 410
  article-title: Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer
  publication-title: Clin Exp Metastasis
– volume: 96
  start-page: 235
  year: 2014
  end-page: 241
  article-title: Expression of GRP78 predicts taxane-based therapeutic resistance and recurrence of human gastric cancer
  publication-title: Exp Mol Pathol
– volume: 12
  start-page: 121
  year: 2014
  article-title: Glusose-rekated protein 78 and heparanase expression in oral squamous cell carcinoma: correlation and prognostic significance
  publication-title: World J Surg Oncol
– volume: 75
  start-page: 603
  year: 2010
  end-page: 607
  article-title: Upregulation of GRP78 in renal cell carcinoma and its significance
  publication-title: Urology
– volume: 71
  start-page: 289
  year: 2004
  end-page: 297
  article-title: The ER function BiP is a master regulator of ER function
  publication-title: Mt Sinai J Med
– volume: 9
  start-page: 93
  year: 2015
  end-page: 104
  article-title: Modulation of the unfolded protein response impedes tumor cell adaptation to proteotoxic stress: A PERK for hepatocellular carcinoma therapy
  publication-title: Hepatol Int
– volume: 39
  start-page: 1042
  year: 2008
  end-page: 1049
  article-title: Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas
  publication-title: Hum Pathol
– volume: 32
  start-page: 1028
  year: 2010
  end-page: 1039
  article-title: Positive association of glucose-related protein 78 during oral cancer progression and the prognostic value in oral precancerous lesions
  publication-title: Head Neck
– volume: 70
  start-page: 4550
  year: 2010
  end-page: 4559
  article-title: Targeted nanoparticles that deliver a sustained, specific release of paclitaxel to irradiated tumors
  publication-title: Cancer Res
– volume: 54
  start-page: 135
  year: 1999
  end-page: 146
  article-title: De-regulation of GRP stress protein expression in human breast cancer cell lines
  publication-title: Breast Cancer Res Treat
– volume: 7
  start-page: 201
  year: 2004
  end-page: 203
  article-title: Improving outcomes in gastric cancer over 20 years
  publication-title: Gastric Cancer
– volume: 6
  start-page: 275
  year: 2004
  end-page: 284
  article-title: Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands
  publication-title: Cancer Cell
– volume: 38
  start-page: 1547
  year: 2007
  end-page: 1552
  article-title: Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival
  publication-title: Hum Pathol
– volume: 63
  start-page: 477
  year: 2016
  end-page: 483
  article-title: Prognostic significance of GRP78/BiP expression in patients with stage III/IV hypopharyngeal squamous cell carcinoma
  publication-title: Neoplasma
– volume: 37
  start-page: 13885
  year: 2016
  end-page: 13892
  article-title: Clinical significance of Î2-adrenergic receptor expression in patients with surgically resected gastric adenocarcinoma
  publication-title: Tumor Biol
– volume: 5
  start-page: 741
  year: 2006
  end-page: 744
  article-title: Glucose regulated proteins in cancer progression, drug resistance and immunotherapy
  publication-title: Cancer Biol Ther
– volume: 39
  start-page: 1042
  year: 2008
  ident: 10.3233/CBM-170062_ref13
  article-title: Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2007.11.009
– volume: 70
  start-page: 4550
  year: 2010
  ident: 10.3233/CBM-170062_ref20
  article-title: Targeted nanoparticles that deliver a sustained, specific release of paclitaxel to irradiated tumors
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-10-0339
– volume: 49
  start-page: 55
  year: 2005
  ident: 10.3233/CBM-170062_ref9
  article-title: Expression of endoplasmic reticulum molecular chaperone Grp78 in human lung cancer and its clinical significance
  publication-title: Lung Cancer
  doi: 10.1016/j.lungcan.2004.12.011
– volume: 5
  start-page: 741
  year: 2006
  ident: 10.3233/CBM-170062_ref18
  article-title: Glucose regulated proteins in cancer progression, drug resistance and immunotherapy
  publication-title: Cancer Biol Ther
  doi: 10.4161/cbt.5.7.2970
– volume: 96
  start-page: 235
  year: 2014
  ident: 10.3233/CBM-170062_ref14
  article-title: Expression of GRP78 predicts taxane-based therapeutic resistance and recurrence of human gastric cancer
  publication-title: Exp Mol Pathol
  doi: 10.1016/j.yexmp.2014.02.011
– volume: 54
  start-page: 135
  year: 1999
  ident: 10.3233/CBM-170062_ref4
  article-title: De-regulation of GRP stress protein expression in human breast cancer cell lines
  publication-title: Breast Cancer Res Treat
  doi: 10.1023/A:1006102411439
– volume: 37
  start-page: 13885
  year: 2016
  ident: 10.3233/CBM-170062_ref15
  article-title: Clinical significance of β2-adrenergic receptor expression in patients with surgically resected gastric adenocarcinoma
  publication-title: Tumor Biol
  doi: 10.1007/s13277-016-5139-2
– volume: 6
  start-page: 45
  year: 2006
  ident: 10.3233/CBM-170062_ref3
  article-title: Stress induction of GRP78/BiP and its role in cancer
  publication-title: Curr Mol Med
  doi: 10.2174/156652406775574523
– volume: 12
  start-page: 121
  year: 2014
  ident: 10.3233/CBM-170062_ref5
  article-title: Glusose-rekated protein 78 and heparanase expression in oral squamous cell carcinoma: correlation and prognostic significance
  publication-title: World J Surg Oncol
  doi: 10.1186/1477-7819-12-121
– volume: 109
  start-page: 326
  year: 2010
  ident: 10.3233/CBM-170062_ref7
  article-title: Decreased GRP78 protein expression is a potential prognostic marker of oral squamous cell carcinoma in Taiwan
  publication-title: J Formos Med Assoc
  doi: 10.1016/S0929-6646(10)60060-5
– volume: 78
  start-page: 539
  year: 1994
  ident: 10.3233/CBM-170062_ref17
  article-title: Apoptosis in cancer therapy: crossing the threshold
  publication-title: Cell
  doi: 10.1016/0092-8674(94)90518-5
– volume: 75
  start-page: 603
  year: 2010
  ident: 10.3233/CBM-170062_ref12
  article-title: Upregulation of GRP78 in renal cell carcinoma and its significance
  publication-title: Urology
  doi: 10.1016/j.urology.2009.05.007
– volume: 63
  start-page: 477
  year: 2016
  ident: 10.3233/CBM-170062_ref16
  article-title: Prognostic significance of GRP78/BiP expression in patients with stage III/IV hypopharyngeal squamous cell carcinoma
  publication-title: Neoplasma
  doi: 10.4149/319_151002N513
– volume: 7
  start-page: 201
  year: 2004
  ident: 10.3233/CBM-170062_ref1
  article-title: Improving outcomes in gastric cancer over 20 years
  publication-title: Gastric Cancer
  doi: 10.1007/s10120-004-0289-0
– volume: 38
  start-page: 1547
  year: 2007
  ident: 10.3233/CBM-170062_ref11
  article-title: Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2007.03.014
– volume: 71
  start-page: 289
  year: 2004
  ident: 10.3233/CBM-170062_ref2
  article-title: The ER function BiP is a master regulator of ER function
  publication-title: Mt Sinai J Med
– volume: 32
  start-page: 1028
  year: 2010
  ident: 10.3233/CBM-170062_ref6
  article-title: Positive association of glucose-related protein 78 during oral cancer progression and the prognostic value in oral precancerous lesions
  publication-title: Head Neck
  doi: 10.1002/hed.21287
– volume: 23
  start-page: 401
  year: 2006
  ident: 10.3233/CBM-170062_ref10
  article-title: Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer
  publication-title: Clin Exp Metastasis
  doi: 10.1007/s10585-006-9051-9
– volume: 6
  start-page: 275
  year: 2004
  ident: 10.3233/CBM-170062_ref21
  article-title: Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2004.08.018
– volume: 9
  start-page: 93
  year: 2015
  ident: 10.3233/CBM-170062_ref8
  article-title: Modulation of the unfolded protein response impedes tumor cell adaptation to proteotoxic stress: A PERK for hepatocellular carcinoma therapy
  publication-title: Hepatol Int
  doi: 10.1007/s12072-014-9582-0
– ident: 10.3233/CBM-170062_ref19
  doi: 10.1073/pnas.0807691105
SSID ssj0043129
Score 2.1910975
Snippet PURPOSE: The glucose-regulated protein 78 (GRP78), also referred to as immunoglobulin heavy chain binding protein (BiP) (BiP/GRP78), is a major molecular...
The glucose-regulated protein 78 (GRP78), also referred to as immunoglobulin heavy chain binding protein (BiP) (BiP/GRP78), is a major molecular chaperone in...
PURPOSE: The glucose-regulated protein 78 (GRP78), also referred to as immunoglobulin heavy chain binding protein (BiP) (BiP/GRP78), is a major molecular...
SourceID proquest
pubmed
crossref
sage
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 273
SubjectTerms Adenocarcinoma
Adenocarcinoma - genetics
Adenocarcinoma - metabolism
Adenocarcinoma - pathology
Adult
Age
Aged
Aged, 80 and over
Endoplasmic reticulum
Endoplasmic Reticulum Stress - physiology
Female
Gastric cancer
Heat-Shock Proteins - biosynthesis
Heat-Shock Proteins - genetics
Humans
Immunohistochemistry
Lymph nodes
Male
Medical prognosis
Metastases
Middle Aged
Neoplasms
Patients
Penetration
Prognosis
Stomach Neoplasms - genetics
Stomach Neoplasms - metabolism
Stomach Neoplasms - pathology
Tumors
Young Adult
Title Prognostic role of BiP/GRP78 expression as ER stress in patients with gastric adenocarcinoma
URI https://journals.sagepub.com/doi/full/10.3233/CBM-170062
https://www.ncbi.nlm.nih.gov/pubmed/28854502
https://www.proquest.com/docview/1993972041
https://www.proquest.com/docview/1934281130
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LSyQxEC58gHhZ1ufOrkoWvXjodZL0IzmJo46yoAyDooeFJpPHKjjdyzxg999v1XT34Au89KFTJKGSSlWlvlQBHKAbGxy6x5FvaxvFgttIBXRc0-BlqhMTuJ-hfK_Ty9v4531yvwAPzVuYmoPjHwSrwhnNDmuSbrqNJhGXQsqj085VRInlUnE8nQzz6p67KadBfygwPR1STNsSEvJf1LxrW4RlqsKEIrx80u3f3TSnNurRWUUznmSEykhklcr01Wgvldcbi_QFGmymoLqf4VNtWbKTaiuswYIv1mHlqo6db8Cv3qgkVB02M8IUsjKwzmPv6KLfyxTzf2tEbMHMmJ33WfWIhD0WrE69OmZ0Z8t-G6r0YZnBAwv14Ag7L4dmE2675zenl1FdWyGyMs4mEXotLsk0Glgk8S42sRchxo9W0sg4OI3KUyQDw60YtLWzymmTmoHlDo8kzeUWLBVl4b8As0KoENDS8MrFIXCtDPe27Z0XSqF714LDhmm5rROPU_2LpxwdEGJwjgzOKwa3YH9O-6dKt_Eu1U7D-7zZMDkhETWV3OEt-D5vRmGhCIgpfDklGonuFke93YLtas3mw-Bk0ZpsY-eMFvFZx2_G__oxyTdYFWQAUOgp24GlyWjqd9F8mQz2cOd1zjrdvXoH_gezf-zX
linkProvider SAGE Publications
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LTxsxELYQSJRLBbSFlJcruHBYiB-btY-ACKElKIqC4FBp5fiBItHdKgkSP5-ZXSfiJXHZi2dta8aeh_15hpADCGODg_A48U1tE8mZTVSAwLUVvGjp1ATmK5TvdatzI3_fpXfxHTe-hYkcnBwhrApmVCnruLsFF-L47LSbYE451LtLMq28oqWTdv92MFPAYBKr4mQszRBgkYo6K-mbv1_boXfO5StgV2Vr2qvka3QS6Ukt1TWy4It1styN1-DfyN_euESAHDRThAfSMtDTUe_4ot_LFPVPEdxaUDOh531avweho4LGLKoTisev9N5g0Q5LDegeMGlj6Lz8Z76Tm_b54KyTxDIJiRUymyYQgLg00-Ar4eZ10kjPg4SPVsIIGZwGO8jToWGWD5vaWeW0aZmhZQ60i2biB1ksysJvEmo5VyGA0-CVkyEwrQzztumd50pBpNYghzOm5TbmEMdSFg85xBLI4BwYnNcMbpD9Oe3_OnPGh1TbM97nM9nnCCrUWD2HNciveTOse7zMMIUvH5FGQOTEwAQ3yEYts_kwMFlwDJvQOUUhvuj43fg_PyfZI186g-5VfnV5_WeLrHC063ijlG2Txen40e-AVzId7sZV-AyJO9jL
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LTxsxEB5VQUK9VJS2NDRQo_bSw5b4sVn7yCtAW1AUgcoBaeX4UUVqd1EeUn8-M1knKlCJy148a1sz9jzszzMAnzGMjR7D4yx0jcuU4C7TEQPXXgyyZ3IbeVigfC97Z9fq201-k44u6C1M4uD0K8GqcEYLZU27-85H2uFSSLl_dHiRUV450r1riorntmDtoD_8ebVUwmgWFwXKeF4QyCKXTWbSR38_tEVPHMwH4K6FvelvwKvkKLKDRrKv4UWoNmH9Il2Fv4HbwaQmkBw2M4IIsjqyw_Fg_3Q4KDQLfxPAtWJ2yk6GrHkTwsYVS5lUp4yOYNkvS4U7HLOof9CsTbDz-o99C9f9k6ujsyyVSsicVMUswyDE54VBf4k2sFdWBREVfoyWVqroDdpCkY8sd2LUNd5pb2zPjhz3qGEMl--gVdVVeA_MCaFjRMchaK9i5EZbHlw3-CC0xmitDV-WTCtdyiNO5Sx-lxhPEINLZHDZMLgNn1a0d032jP9SdZa8L5fyLwlYaKiCDm_D3qoZ1z5daNgq1HOikRg9cTTDbdhqZLYaBieLzmEXO2ckxH86fjL-9vMkH2F9cNwvf5xffv8ALwWZdrpUKjrQmk3mYQcdk9loNy3Ce-_S2eQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prognostic+role+of+BiP%2FGRP78+expression+as+ER+stress+in+patients+with+gastric+adenocarcinoma&rft.jtitle=Cancer+biomarkers+%3A+section+A+of+Disease+markers&rft.au=Ogawa%2C+Hiroomi&rft.au=Kaira%2C+Kyoichi&rft.au=Takahashi%2C+Kengo&rft.au=Shimizu%2C+Akira&rft.date=2017-09-07&rft.eissn=1875-8592&rft.volume=20&rft.issue=3&rft.spage=273&rft_id=info:doi/10.3233%2FCBM-170062&rft_id=info%3Apmid%2F28854502&rft.externalDocID=28854502
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1574-0153&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1574-0153&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1574-0153&client=summon